Subcategories
| No. | Category | Technology Name | Briefcase | Lead Researcher |
|---|---|---|---|---|
| 594 |  |
Validated approach in small animals and human cell models
Categories
Ceramide, apoptosis, cancer, sphingolipids, prostate cancer
Development Stage
Considerable anticancer activity in vivo in prostate, colon, pancreas and melanoma mouse ... More | Dagan Arie | |
| 4283 | |
Application
No two cancers are the same, and it can be difficult to predict which tumors are slow-growing and which are likely to grow and spread to other parts of the body. Current medical society guidelines rely on cancer stage to determine ... More | Smith Yoav | |
| 2319 | |
Category
Medical Sciences, Stem cells, Small molecules Our Innovation
Improved removal of PSCs may be obtained by identifying small molecules that selectively perturb crucial pathways in PSCs, and thus induce cell death in these cells ... More | Benvenisty Nissim | |
| 3177 | |
Categories
Diagnostics, Research
Development Stage
In vitro and in-vivo proof of concept; ongoing research
Patent Status
US, Europe and China applications filed based on WO 2017/025968
Background
Fluorescence guided surgery is currently ... More | Yavin Eylon | |
| 3107 | |
Categories
Treatment of cancer, neurodegeneration and infectious diseases.
Development Stage
In vitro proof of concept; in vivo POC
Patent Status
PCT publication number : WO2016/142948Highlights
A new technology to inhibit the activity ... More | Karni Rotem | |
| 2622 | |
A specific therapy for treating this serious disease
Categories
Mastocytosis, Cancer
Development Stage
Proof-of-concept, preclinical
Patent Status
Patent Pending
Market
Mastocytosis, Mast Cell Leukemia, AllergiesBackground
Mast cells ... More | Levi-Schaffer Francesca | |
| 4511 | |
Keywords
Epigenetics, Dual-specificity, Enzymes, anti-cancer
Current Development Stage
TRL3 - Hypothesis testing and initial POC demonstrated Application
Cancer cells lose their epigenetic checks and balances followed by unscheduled ... More | Ben-Sasson Shmuel | |
| 4496 | |
Keywords
Glioblastoma multiforme, regulatory networks, target genes
Current development stage
TRL3 - hypothesis testing and initial POC demonstrated in-vitro Application
Glioblastoma multiforme (GBM) is a common, very aggressive brain ... More | Hellman Asaf | |
| 4664 | |
Additional information will be provided upon request
More | Golomb Gershon | |
| 4537 | |
Additional information will be provided upon request
More | Mandelboim Ofer | |
| 4379 | |
Additional information will be provided upon request
More | Mechoulam Raphael | |
| 4381 | |
Additional information will be provided upon request
More | Benny Ofra | |
| 4591 | |
Additional information will be provided upon request
More | Karni Rotem | |
| 4471 | |
Additional information will be provided upon request
More | Domb Abraham | |
| 4273 | |
Additional information will be provided upon request
More | Shifman Julia | |
| 198 | |
Categories
Superactive High Afinity Leptin antagonist, mutein, multiple sclerosis, inflammatory bowel syndrome, rheumatoid arthritis, fibrosis, cardiovascular disease, CKD Cachexia, Osteoarthritis
Development Stage
(1) In vivo tests in ... More | Gertler Arieh | |
| 1706 | |
Delivery of chemically modified gluococorticoids (GC) into the tumor site by passive loading
Categories
Drug delivery for anticancer treatments, Glucocorticoids (GCs)
Development Stage
In vivo animal studies for anticancer therapy were ... More | Barenholz Yechezkel |
- 1
- 2